• 24 NOV 17

    PLCb1-SHP-2 complex, PLCb1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling?

    Abstract

    Background: Angiotensin II (Ang II) signaling occurs via two major receptors which activate non-receptor tyrosinkinases that then interact with protein tyrosin-phosphatases (PTPs) to regulate cell function. SHP-2 is one suchimportant PTP that also functions as an adaptor to promote downstream signaling pathway. Its role in Ang IIsignaling remains to be clarified.Results: Using cultured normal human fibroblasts, immunoprecipitation and western blots, we show for the firsttime that SHP-2 and PLCb1 are present as a preformed complex. Complex PLCb1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCb1 complexes and caused complex associated PLCb1 tyr-phosphorylation to decline while complex associated SHP-2’s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan’s effects. Moreover, Ang II induced both increased complex phosphatase activity and decreased complex associated PLCb1 tyr-phosphorylation, the latter response required regulator of G protein signaling (RGS)-2.

    Conclusions: Ang II signals are shown for the first time to involve a preformed SHP-2-PLCb1 complex. Changes in

    the complex’s PLCb1 tyr-phosphorylation and SHP-2’s tyr-phosphorylation as well as SHP-2-PLCb1 complex

    formation are the result of Ang II type 1 receptor activation with changes in complex associated PLCb1 tyrphosphorylation requiring RGS-2. These findings might significantly expand the number and complexity of Ang II

    signaling pathways. Further studies are needed to delineate the role/s of this complex in the Ang II signaling

    system.

    Keywords: Angiotensin II signaling, SHP-2, PLCβ1, SHP-2-PLCβ1 complex

    PLCβ1-SHP-2 complex, PLCβ1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling?

Contatti

Per informazioni è possibile contattarci ai seguenti recapiti:

  • Email: foricaonlus.padova@gmail.com

  • Tel.: +39 049-821-2260

  • Tel: +39 049-821-2279

  • Fax: +39 049-875-4179

Dona ora

Il tuo contributo è prezioso per sostenere la ricerca cardiovascolare dei nostri ricercatori, e per diffondere nella popolazione la conoscenza del problema “ipertensione”. Ciò permette di evitare che molte persone, spesso giovani, incorrano nelle temibili complicanze dell’Ipertensione Arteriosa non diagnosticata in tempo.